RA drug benefits 'not different'

Anti-tumour necrosis factor (TNF) drugs have the same clinical efficacy as other DMARDs, say US and Austrian researchers.

Anti-TNF drugs in combination with methotrexate are recommended as a second-line treatment for rheumatoid arthritis (RA) if patients fail to respond to DMARDs, according to NICE.

But a systematic review of 23 head-to-head trials into RA drugs showed no major or clinically important differences between the two types of drugs when used as monotherapy.

All of the trials studied included at least 100 participants and 12 weeks' follow-up. Anti-TNF drugs studied included adalimumab, etanercept and infliximab, and DMARDs were limited to methotrexate, leflunomide and sulfasalazine.

In trials comparing monotherapy with each type of drug, anti-TNF drugs resulted in better radiographic outcomes than other DMARDs.

However, when the American College of Rheumatology (ACR) response criteria was considered there was little difference in outcomes for ACR 20, 50 or 70 response rates.

Overall, combinations of treatment were found to be more effective than monotherapy.

But there is insufficient evidence to decide which combination is best, said the researchers.

They warn that, because most of the studies considered were short term, long-term safety issues may change the benefit and harm ratios of the different types of drugs.

rachel.liddle@haymarket.com

Annals of Internal Medicine 2007 Online

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Viewpoint: Why NICE guidance on domestic abuse needs to be updated

Viewpoint: Why NICE guidance on domestic abuse needs to be updated

Dr Vasumathy Sivarajasingam explains why screening for domestic abuse should be standard...

PCNs forced to opt out of phase 2 of COVID-19 vaccination programme over workload pressure

PCNs forced to opt out of phase 2 of COVID-19 vaccination programme over workload pressure

Some PCNs have opted out of phase 2 of the COVID-19 vaccination programme, with others...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

CVT risk from COVID-19 infection 'significantly higher' than from vaccines, study suggests

CVT risk from COVID-19 infection 'significantly higher' than from vaccines, study suggests

The risk of cerebral venous thrombosis (CVT) following COVID-19 infection is eight...

‘Warm and kind’ retired Derbyshire GP dies from COVID-19

‘Warm and kind’ retired Derbyshire GP dies from COVID-19

Retired Derbyshire GP Dr Om Prakash Chawla, who was known for his warmth and kindness,...

GPs can learn from pandemic to strengthen relationship with patients, says RCGP chair

GPs can learn from pandemic to strengthen relationship with patients, says RCGP chair

General practice can build on changes to care during the COVID-19 pandemic to strengthen...